University of Hull
Also known as: Castle Hill Hospital | Castle Hill Hospital, Hull | Daniel Carradice | Hull and East Yorkshire Hospitals NHS Trust | Hull and east Yorkshire NHS trust | Hull & East Yorkshire NHS Trust (Castle Hill Hospital), United Kingdom | Hull Royal Infirmary | Hull Royal Infirmary, Hull, United Kingdom. | Hull University | Hull York Medical School | Multiple Sclerosis Clinic - Hull Hospital | Queen's Centre for Haematology & Oncology, Castle Hill Hospital, Cottingham | Spire Hull and East Riding Hospital | United Kingdom: Hull University | University of Hull | University of Hull/Hull and East Yorkshire Hospitals NHS Trust | University of Hull, Hull York Medical School, Castle Hill Hospital | University of Hull, UK
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2003Last known activity
Feb 16, 2023
Timeline
1920s
- Jan 1, 1927
University of Hull— Founded
Drugs by trial phase (70 distinct, 40 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Other trials (14 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Aneurysm
- Anxiety Disorders
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Atrial Fibrillation
- Bronchial Hyperreactivity
- Cerebral Hemorrhage
- Cicatrix
- Communicable Diseases
- Cough
- Diarrhea
- Fibrosis
- Glioblastoma
- Heart Failure
- Hemorrhage
- Idiopathic Pulmonary Fibrosis
- Infections
- Leg Ulcer
- Lung Diseases
- Lung Diseases, Obstructive
- Multiple Sclerosis
- Myocardial Reperfusion Injury
- Pancreatic Neoplasms
- Polycystic Ovary Syndrome
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Rectal Neoplasms
- Reperfusion Injury
- Sarcoidosis
- Sarcoidosis, Pulmonary
- Sclerosis
- Surgical Wound Infection
- Syndrome
- Thromboembolism
- Tissue Adhesions
- Ulcer
- Varicose Ulcer
- Varicose Veins
- Venous Insufficiency
- Wound Infection
- Wounds and Injuries
Recent trials (50)
- NCT05744128CollaboratorPhase 2Feb 16, 2023
- NCT05744128OfficialPhase 2Feb 16, 2023
- NCT05646199Lead sponsorPhase 2/Phase 3Jan 31, 2023
- NCT05646199Overall official - principal investigatorPhase 2/Phase 3Jan 31, 2023
- NCT05646199Reponsible party - principal investigatorPhase 2/Phase 3Jan 31, 2023
- NCT04020380Lead sponsorPhase 2Jul 31, 2019
- NCT04020380Overall official - principal investigatorPhase 2Jul 31, 2019
- NCT03996772CollaboratorPhase 3Jun 3, 2019
- NCT03415269Overall official - principal investigatorPhase 2Feb 28, 2018
- NCT03415269Lead sponsorPhase 2Feb 28, 2018
- NCT03008551Lead sponsorPhase 2/Phase 3Jun 1, 2017
- NCT03008551Overall official - principal investigatorPhase 2/Phase 3Jun 1, 2017
- NCT03008551Reponsible party - principal investigatorPhase 2/Phase 3Jun 1, 2017
- NCT03102801Reponsible party - principal investigatorN/ADec 1, 2016
- NCT03102801Lead sponsorN/ADec 1, 2016
Details
- Founded
- Hull, GB Jan 1, 1927
- Last known activity
- Feb 16, 2023